Arguments for a comprehensive metabolic evaluation of the first-time stone former

Journal of the Canadian Urological Association

Volumn 4, Issue 3, 2010, Pages 209-210

  Paterson, Ryan F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953723090     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.10072     Document Type: Article

References (18)

1. Yagisawa T, Chandhoke PS, Fan J. Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation. Urology 1998;52:750-755.
2. Parks JH, Goldfisher E, Asplin JR, et al. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Uaol 2002;167:1607-1612.
3. Pak CY. Should patients with single renal stone occurrence undergo diagnostic evaluation? J Urol 1982;127:855-858.
4. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-84.
5. Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol 2005;1 73:848-857.
6. Yuruk E, Binbay M, Sari E, et al. A prospective, randomized trial of management for asymptomatic lower pole calculi. J Urol 2010;183:1424-1428.
7. Lotan Y, Pearle MS. Economics of stone management. Urol Clin North Am 2007;34:443-453.
8. Hosking DH, Erickson SB, Van den Berg CJ, et al. The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 1983; 130:1115-1118.
9. Parks JH, Coe FL. The financial effects of kidney stone prevention. Kidney Int 1996;50:1706-1712.
10. Lingeman J, Mardis H, Kahnoski R, et al. Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol 1998;160:1629-1634.
11. Parks JH, Coe FL. Evidence for durable kidney stone prevention over several decades. BJU Int 2009;103:1238-1246.
12. Bensalah K, Tuncel A, Raman JD, et al. How physician and patient perceptions differ regarding medical management of stone disease. J Urol 2009;182:998-1004.
13. Lotan Y, Cadeddu JA, Roerhborn CG, et al. Cost-effectiveness of medical management strategies for nephrolithiasis. J Urol 2004;172:2275-2281.
14. Lee YH, Huang WC, Tsai JY, et al. The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study. I Urol 1999161:1453-1457.
15. Mandel N, Mandel I, Fryjoff K, et al. Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes. J Urol 2003;169:2026-2029.
16. Parks JH, Worcester EM, Coe FL, et al. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 2004;66:777-785.
17. Flegel K, Magner P. Get excess salt out of our diet. CMAJ 2009;180:263.
18. Cassels A. Move over war on transfats; make way for the war on salt. CMAJ 2008; 178:256.